Pacer Advisors Inc. Increases Position in Option Care Health, Inc. (NASDAQ:OPCH)

Pacer Advisors Inc. lifted its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 2.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 25,483 shares of the company’s stock after acquiring an additional 537 shares during the quarter. Pacer Advisors Inc.’s holdings in Option Care Health were worth $591,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also modified their holdings of OPCH. UMB Bank n.a. boosted its stake in Option Care Health by 937.5% in the third quarter. UMB Bank n.a. now owns 830 shares of the company’s stock valued at $26,000 after acquiring an additional 750 shares during the period. GAMMA Investing LLC boosted its position in shares of Option Care Health by 110.6% during the third quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after buying an additional 471 shares during the period. Whittier Trust Co. of Nevada Inc. boosted its position in shares of Option Care Health by 3,362.8% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock worth $47,000 after buying an additional 1,446 shares during the period. International Assets Investment Management LLC boosted its position in shares of Option Care Health by 3,029.7% during the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock worth $91,000 after buying an additional 2,757 shares during the period. Finally, Quarry LP boosted its position in shares of Option Care Health by 327.7% during the third quarter. Quarry LP now owns 3,430 shares of the company’s stock worth $107,000 after buying an additional 2,628 shares during the period. 98.05% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

OPCH has been the topic of several recent analyst reports. Truist Financial dropped their target price on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a report on Friday, November 1st. UBS Group initiated coverage on Option Care Health in a report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price target on the stock. JMP Securities reaffirmed a “market outperform” rating and issued a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a report on Friday, January 10th. JPMorgan Chase & Co. upped their price target on Option Care Health from $38.00 to $40.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Finally, The Goldman Sachs Group cut Option Care Health from a “buy” rating to a “neutral” rating and dropped their price target for the company from $38.00 to $27.00 in a report on Monday, November 4th. Two analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $32.25.

Insider Activity

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the stock in a transaction dated Friday, November 8th. The shares were acquired at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the acquisition, the director now directly owns 326,334 shares in the company, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.64% of the stock is currently owned by corporate insiders.

Option Care Health Trading Down 0.8 %

Option Care Health stock opened at $30.68 on Tuesday. The company’s fifty day simple moving average is $25.31 and its 200-day simple moving average is $27.87. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $34.63. The stock has a market cap of $5.22 billion, a P/E ratio of 25.78, a P/E/G ratio of 2.19 and a beta of 1.31.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.